In today’s recent session, 0.56 million shares of the Silexion Therapeutics Corp (NASDAQ:SLXN) have been traded, and its beta is -0.03. Most recently the company’s share price was $0.80, and it changed around -$0.08 or -9.10% from the last close, which brings the market valuation of the company to $3.20M. SLXN at last check was trading at a discount to its 52-week high of $122.02, offering almost -15152.5% off that amount. The share price’s 52-week low was $0.84, which indicates that the recent value has fallen by an impressive -5.0% since then. We note from Silexion Therapeutics Corp’s average daily trading volume that its 10-day average is 2.5 million shares, with the 3-month average coming to 1.19 million.

Silexion Therapeutics Corp stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SLXN as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Silexion Therapeutics Corp is expected to report earnings per share of 0 for the current quarter.

Silexion Therapeutics Corp (NASDAQ:SLXN) trade information

Instantly SLXN has been showing red trend so far today with a performance of -9.10% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.9400 on recent trading dayincreased the stock’s daily price by 58.76%. The company’s shares are currently down -60.20% year-to-date, but still down -56.76% over the last five days. On the other hand, Silexion Therapeutics Corp (NASDAQ:SLXN) is -72.42% down in the 30-day period. We can see from the shorts that 35842.0 shares have been sold at a short interest cover period of 0.23 day(s).